We develop therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Our two core programs are: Disc/Spine Program brtxDISCTM : Our lead cell therapy candidate, BRTX , is a product formulated from autologous cultured mesenchymal stem cells collected from bone marrow. We intend that the product will be used for the non surgical treatment of protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease. The treatment is intended for patients whose pain has not been alleviated by non invasive procedures and who potentially face the prospect of surgery. We have received clearance from the Food and Drug Administration to commence a Phase clinical trial using BRTX to treat chronic lower back pain due to degenerative disc disease related to protruding/bulging discs. Metabolic Program ThermoStem : We are developing a cell based therapy to target obesity and metabolic disorders using brown adipose fat derived stem cells to generate brown adipose tissue BAT . BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes.
Quote | BioRestorative Therapies Inc (OTCMKTS:BRTX)
Last: | $7.02 |
---|---|
Change Percent: | 0.0% |
Open: | $7.85 |
Close: | $7.02 |
High: | $7.85 |
Low: | $6.6 |
Volume: | 208,081 |
Last Trade Date Time: | 11/08/2021 04:54:29 pm |
News | BioRestorative Therapies Inc (OTCMKTS:BRTX)
– Adds to comprehensive patent portfolio underlying novel ThermoStem ® technology platform – – Expanding intellectual property estate expected to help drive ThermoStem ® licensing opportunities – – Substantive di...
2024-06-17 08:20:45 ET More on BioRestorative Therapies BioRestorative Therapies, Inc. (BRTX) Q1 2024 Earnings Call Transcript BioRestorative spikes on talks for a potential licensing pact BioRestorative Therapies receives Nasdaq notice of non-compliance Seek...
Message Board Posts | BioRestorative Therapies Inc (OTCMKTS:BRTX)
Subject | By | Source | When |
---|---|---|---|
$BRTX | Hole shot King | investorshub | 07/06/2023 5:01:13 PM |
$BRTX bears are running | iflyboats | investorshub | 07/06/2023 8:35:29 AM |
$BRTX bears are running | 50 MIL STRONG | investorshub | 07/01/2023 6:15:19 PM |
$BRTX MomentumIts trading | trader59 | investorshub | 07/01/2023 1:09:02 PM |
Between the two, I'd vote Auctus, given the | I ll be back | investorshub | 06/30/2023 1:39:39 PM |
News, Short Squeeze, Breakout and More Instantly...
BioRestorative Therapies Inc Company Name:
BRTX Stock Symbol:
OTCMKTS Market:
– Adds to comprehensive patent portfolio underlying novel ThermoStem ® technology platform – – Expanding intellectual property estate expected to help drive ThermoStem ® licensing opportunities – – Substantive di...
- Significant YoY improvement in operating performance - - Ends Q1-2024 with $16.4 million cash, cash equivalents, and marketable securities - MELVILLE, N.Y., June 17, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX ...
2024-06-14 06:02:00 ET Why New Investors Should Look Into Investing in Penny Stocks Penny stocks offer an intriguing entry point for new investors looking to tap into the stock market without a substantial initial investment. These stocks, typically priced under $5, allow individuals to...